LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Peptide containing doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Aniline-derived ligands for the thyroid receptor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Aniline-derived ligands for the thyroid receptor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Animal growth promotant and method of use for animal growth

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Animal model for AIDS

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Animal models of human amyloidoses

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Anorexigenic and hypotensive peptides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonist peptides to the C5A chemotactic function of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonist peptides to VEGF receptor Flt-1

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonistic analogs of GH RH (2003)

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonistic analogs of GH-RH inhibiting IGF-I and -II

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonistic peptides of prostaglandin E2 receptor subtype EP4

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonists of calcitonin gene-related peptide

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonists of G-protein-coupled receptor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonists of gonadotropin releasing hormone

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonists of gonadotropin releasing hormone

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonists of HMG1 for treating inflammatory conditions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonists of HMG1 for treating inflammatory conditions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonists of HMG1 for treating inflammatory conditions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Antagonists of intestinotrophic GLP-2 peptides